Dr. Lal Path Labs

Dr. Lal Path Labs

LALPATHLAB

 ₹ 2,736.70
 ₹ 9.79
0.36%
Healthcare
 ₹ 0.00
(%)1D
Updated: 23 Apr 2025, 03:31:18 pm IST
Stock Score
Open Price
 ₹ 2,747.52
Prev. Close
 ₹ 2,726.91
 ₹ 2,701.72
Day Low
 ₹ 2,755.13
Day High

 ₹ 2,113.47
52 Week Low
 ₹ 3,594.64
52 Week High

Quick Bite

Price To Earnings Ratio

63.87

Sector PE

67.03

PB Ratio

12.71

Sector PB

8.67

EPS

42.85

Dividend Yield

1.06

Today's Volume

51.314 K

5 Day Avg. Volume

70.495 K

PEG Ratio

1.29

Market Cap.

₹ 22,630.00 Cr.

News & Events

About Dr. Lal Path Labs

Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Dr. Lal Path Labs Share Price

Dr. Lal PathLabs Limited is an Indian company providing diagnostic and related healthcare tests and services. The company's activities include management of biochemistry, haematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology and other pathological and radiological research laboratories. It offers a variety of condition-based tests, including allergies, diabetes, health checks, viral infections, fever, heart disease, hypertension, cancer, miscarriages, anaemia, arthritis, breast cancer, diphtheria, liver disease, bone disease, abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscle disorders and viral infections. The company's subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited and Dr. Lal PathLabs Nepal Private Limited.

Dr. Lal Path Labs FAQs

How to Buy Dr. Lal Path Labs Share?

up
To purchase Dr. Lal Path Labs shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Dr. Lal Path Labs (ticker symbol: LALPATHLAB) on the trading platform provided by your broker and purchase the shares.

What's Dr. Lal Path Labs share price today?

up
The stock price of Dr. Lal Path Labs as of 25 Apr 2025 is ₹2,736.70

What is the Market Cap of Dr. Lal Path Labs?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 25 Apr 2025, Dr. Lal Path Labs (ticker symbol: LALPATHLAB) has a market capitalisation of approximately ₹2,26,30,00,00,000.00

What is the PE and PB ratio of Dr. Lal Path Labs?

up
Dr. Lal Path Labs Ltd's price-to-book ratio as of 25 Apr 2025 is 12.71, reflecting the market's valuation compared to its asset value. As of 25 Apr 2025, the trailing twelve months P/E (price-to-earnings) ratio is 63.87, indicating the market values the company at around ₹63.87 for every ₹1 of earnings

What is the 52 Week High and Low of Dr. Lal Path Labs Share?

up
Dr. Lal Path Labs Ltd (LALPATHLAB) hit its 52-week high at ₹3,594.64, and its 52-week low at ₹2,113.47.
Begin your investment journey today
Login/Register
View All Global Indices
View More
Start Now